{"nct_id":"NCT05512390","title":"A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2023-04-26","start_date_type":"ACTUAL","primary_completion_date":"2027-02","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}